Rantus Pharma Private Limited - Due diligence report

A 360° intelligence report on Rantus Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2003-02-07 Hyderabad, Telangana Active Unlisted
Share
Connect MCP
RP Rantus Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Rantus Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
59/100
Trust Score
Moderate

Rantus Pharma Private Limited is assessed as Moderate with a Trust Score of 59/100. Rantus Pharma Private Limited is an active private limited indian non-government company incorporated in 2003, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 12 Oct 2026 from the latest processed filings. Rantus Pharma Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
59/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
38/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).

Charges position: 0 open (-) · 5 satisfied (39.46 cr).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India4 48.0 cr
Uco Bank1 48.0 cr
Compliance Score: 38/100 Caution Indicated
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2019 - filings overdue.
  • Flagged by authority: MCA.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
UMAMAHESWARA RAO KOTTE 01234567 Director 01/04/2018 6 yrs Approved
RATNA KUMARI KOTTI 01234567 Director 01/04/2018 6 yrs Approved
SOUDHAMINI NARRAVULA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • UMAMAHESWARA RAO KOTTE has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: UMAMAHESWARA RAO KOTTE (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 80
Growth signals & trust indicators
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (38/100).
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence57/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment49/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view48/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
26 Sep 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
07 Apr 2017
Charge satisfied
State Bank Of India
22 Oct 2014
Charge satisfied
State Bank Of India
28 Jun 2013
Securities allotted
900000 Equity Shares Without Differential Rights - 90.00 Lakh raised
21 Mar 2012
Securities allotted
900000 Equity Shares Without Differential Rights - 90.00 Lakh raised
18 Jan 2010
Securities allotted
850000 Equity Shares Without Differential Rights - 85.00 Lakh raised
31 Dec 2009
Securities allotted
850000 Equity Shares Without Differential Rights - 85.00 Lakh raised
18 Aug 2009
Charge created
State Bank Of India - 11.36 cr
01 Dec 2008
Charge satisfied
Uco Bank
15 Nov 2008
Charge created
State Bank Of India - 9.40 cr
08 Oct 2008
Charge created
State Bank Of India - 8.70 cr
29 Mar 2007
Charge created
State Bank Of India - 7.00 cr
14 Feb 2005
Charge created
Uco Bank - 3.00 cr
17 Feb 2003
Director appointed
RATNA KUMARI KOTTI (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
3 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
All 5 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Way2Begin Private Limited U93290TS2023PTC176198 Hyderabad, Telangana
Arbi Fast Food Chain Private Limited U15494TG2008PTC058102 Hyderabad, Telangana
Shri Kartikeya Life Spaces Private Limited U70109TG2018PTC121682 Hyderabad, Telangana
Maxis Digital Solutions Private Limited U62099TS2023PTC179722 Hyderabad, Telangana
Adri Infotech Services Private Limited U72200TG2009PTC066357 Hyderabad, Telangana
P And P Constructions Pvt Ltd U45200TG1992PTC015113 Hyderabad, Telangana
Adoclock Media Private Limited U73100TS2023PTC174299 Hyderabad, Telangana
Sentel Software Private Limited U72200TG2017PTC120513 Hyderabad, Telangana
Mgm Hatcheries Private Limited U01229TG1984PTC004735 Hyderabad, Telangana
Opsdigi Systems Private Limited U72900TG2022PTC169505 Hyderabad, Telangana
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Rantus Pharma Private Limited before audits and certifications: compliance score 38/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Rantus Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Rantus Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 59/100, distress signals and MSME payment-delay disclosures - know whether Rantus Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Rantus Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Rantus Pharma Private Limited an active company?

Rantus Pharma Private Limited has MCA status “Active” with a compliance score of 38/100 (Caution Indicated).

Is Rantus Pharma Private Limited financially healthy?

Rantus Pharma Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Rantus Pharma Private Limited?

Its overall Trust Score is 59/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Rantus Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Rantus Pharma Private Limited have loans or charges against its assets?

No open charges - all 5 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Rantus Pharma Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 38/100 (Caution Indicated).

Is it risky to lend to Rantus Pharma Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.